Advocacy intelligence hub — real-time data for patient organizations
National Institute of Allergy and Infectious Diseases (NIAID) — PHASE2
University of Alabama at Birmingham — PHASE2
Boston University — NA
University Hospital Schleswig-Holstein — PHASE2, PHASE3
University College, London — PHASE3
University of Namibia
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
James Andrews, MD
University of Alabama at Birmingham
Raaphorst, MD, PhD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Jim Bush, MBChB, PhD
Fortrea Clinical Research Unit Ltd.
Nan Shen, MD & PhD
Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University
Louise Pyndt Diederichsen, PhD
Rigshospitalet, Denmark
Yun Yuan
Peking University First Hospital